Altimmune (ALT) Accumulated Expenses (2010 - 2026)
Altimmune's Accumulated Expenses was $11.23 million in Q2 2026, up 34.2% from $8.37 million a year earlier and up 14.7% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Altimmune came in at $12.28 million, up 19.7% from FY2024.
- Accumulated Expenses shows a five-year compound annual growth rate of 1.5% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $10.26 million in FY2024 (+1.8%), $10.07 million in FY2023 (-17.8%), $12.25 million in FY2022 (+20.7%) and $10.15 million in FY2021 (-11.0%).
- Quarterly Accumulated Expenses has moved between $7.4 million (Q2 2023) and $19.12 million (Q3 2021) over five years.
- Compared with a year earlier, Accumulated Expenses has increased for four straight quarters, with growth averaging 4.9% over the last eight quarters.
- The best year-over-year quarter for Accumulated Expenses over five years was Q3 2021 (growth of 252.9%); the worst was Q3 2023 (a decline of 38.4%).
- Per Business Quant data, ALT's Accumulated Expenses in the three quarters before Q2 2026 was $9.79 million (Q1 2026), $12.28 million (Q4 2025) and $7.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Altimmune | 556.20 Mn | 556.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.23 Mn |
| Mar 31, 2026 | 9.79 Mn |
| Dec 31, 2025 | 12.28 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Jun 30, 2025 | 8.37 Mn |
| Mar 31, 2025 | 8.72 Mn |
| Dec 31, 2024 | 10.26 Mn |
| Sep 30, 2024 | 7.51 Mn |
| Jun 30, 2024 | 12.47 Mn |
| Mar 31, 2024 | 7.57 Mn |
| Dec 31, 2023 | 10.07 Mn |
| Sep 30, 2023 | 8.83 Mn |
| Jun 30, 2023 | 7.40 Mn |
| Mar 31, 2023 | 9.71 Mn |
| Dec 31, 2022 | 12.25 Mn |
| Sep 30, 2022 | 14.32 Mn |
| Jun 30, 2022 | 10.97 Mn |
| Mar 31, 2022 | 12.61 Mn |
| Dec 31, 2021 | 10.15 Mn |
| Sep 30, 2021 | 19.12 Mn |
API Access
Altimmune Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();